…[esketamine] touted a new antidepressant as a solution for veterans
“This was supposed to be a big game-changer,” said Dr. Erick Turner, a psychiatrist at Oregon Health and Science University. But the data on the drug (esketamine) was “nothing to write home about,” he added. Johnson & Johnson, which owns Janssen, submitted five studies in its application to the FDA, only two of which were…
Recent Comments